Search Results - "Chatzinikolaou, M L"

P738 Real world outcomes on the efficacy and safety of combination of biologic and immunosuppressive therapy in liver transplant recipients with inflammatory bowel disease by Chatzinikolaou, M L, O’Shea, N, Erian, G, Koutsoumpas, A, Ryan, J, Hamilton, M, Murray, C

“…Abstract Background Following liver transplantation (LT), more than a third of patients with inflammatory bowel disease (IBD) will have an aggressive disease…”
Get full text

P942 Real-world data on outcomes of treatment with ustekinumab in patients with Ulcerative Colitis by Chalakatevaki, K, Kokkotis, G, Chatzinikolaou, M L, Anagnostopoulou, E, Argiriou, K, Viazis, N, Galanopoulos, M, Gerasimatos, G, Giouleme, O, Zampeli, E, Zacharopoulou, E, Theodoropoulou, A, Theocharis, G, Kalogirou, M, Karatzas, P, Karmiris, K, Kapsoritakis, A, Koustenis, K, Koutroumpakis, I, Kiriakos, N, Lazou, D, Liatsos, C, Mantaka, A, Mantzaris, G, Michalopoulos, G, Michopoulos, S, Orfanidou, A, Papathanasiou, E, Polymeros, D, Potamianos, S, Sotiropoulos, C, Soufleris, K, Tzouvala, M, Foteinogiannopoulou, K, Chatzidakis, A, Psistakis, A, Bamias, G

“…Abstract Background Ustekinumab (UST), a monoclonal antibody against the shared p40 subunit of IL-12/IL-23, has been approved for the treatment of moderate to…”
Get full text

P370 Concomitant azathioprine prevents new-onset arthralgia after initiation of vedolizumab: A retrospective cohort study by Kokkotis, G, Zampeli, E, Tzouvala, M, Giotis, I, Orfanos, P, Benetou, V, Stoupaki, M, Gizis, M, Kioulos, N, Kitsou, V, Leontidis, N, Leonidakis, G, Chatzinikolaou, M L, Perlepe, N, Koutsounas, I, Lagiou, P, Michopoulos, S, Bamias, G

“…Abstract Background Vedolizumab is a monoclonal antibody against the gut-homing integrin α4β7 that is being used for the treatment of moderate to severe…”
Get full text

P406 Observational study of the effectiveness of vedolizumab on treatment outcomes and health-related quality of life in biologic-naïve patients with Inflammatory Bowel Diseases in Greece – the TROVE study - Interim Analysis by Chatzinikolaou, M L, Kifnidi, C, Kokkotis, G, Gatopoulou, A, Michopoulos, S, Soufleris, K, Poulopoulos, G, Theodoropoulou, A, Mantzaris, G, Ntelis, V, Papatheodoridis, G, Tzouvala, M, Koutroubakis, I E, Theocharis, G, Kourikou, A, Christodoulou, D, Grammatopoulos, A, Michalopoulos, G, Georgopoulos, S, Akriviadis, E, Vradelis, S, Gkagkari, V, Zampeli, E, Fasoulas, K, Charalampidis, M, Velegraki, M, Karampekos, G, Viazis, N, Andrianakou, G, Karatzas, P, Tribonias, G, Zacharopoulou, E, Orfanoudaki, E, Tsellou, E, Psyrilos, A, Roussou, D, Bamias, G

“…Abstract Background Vedolizumab (VDZ), a gut-selective anti-lymphocyte trafficking (GSALT), anti-α4b7 integrin antibody, is an approved and effective treatment…”
Get full text